58 related articles for article (PubMed ID: 10084728)
1. Pediatric renal transplantation under tacrolimus-based immunosuppression.
Shapiro R; Scantlebury VP; Jordan ML; Vivas C; Ellis D; Lombardozzi-Lane S; Gilboa N; Gritsch HA; Irish W; McCauley J; Fung JJ; Hakala TR; Simmons RL; Starzl TE
Transplantation; 1999 Jan; 67(2):299-303. PubMed ID: 10075598
[TBL] [Abstract][Full Text] [Related]
2. Tacrolimus-based immunosuppression in pediatric renal transplantation.
Jordan ML; Shapiro R; Scantlebury V; Vivas C; Ellis D; Lombardozzi-Lane S; Starzl TE
Transplant Proc; 1999 Nov; 31(7A):29S-30S. PubMed ID: 10576039
[No Abstract] [Full Text] [Related]
3. Renal transplantation at the University of Pittsburgh: the impact of FK506.
Shapiro R; Jordan M; Scantlebury VP; Vivas C; Gritsch HA; Rao AS; Trucco M; Zeevi A; Demetris AJ; Randhawa P
Clin Transpl; 1994; ():229-36. PubMed ID: 7547544
[TBL] [Abstract][Full Text] [Related]
4. FK506 in pediatric kidney transplantation--primary and rescue experience.
Shapiro R; Scantlebury VP; Jordan ML; Vivas C; Tzakis AG; Ellis D; Gilboa N; Hopp L; McCauley J; Irish W
Pediatr Nephrol; 1995; 9 Suppl(Suppl):S43-8. PubMed ID: 7492486
[TBL] [Abstract][Full Text] [Related]
5. Pediatric kidney transplantation at the University of Pittsburgh.
Scantlebury VP; Shapiro R; Tzakis A; Jordan ML; Vivas C; Ellis D; Gilboa N; Hopp L; Irish W; Mitchell S
Transplant Proc; 1994 Feb; 26(1):46-7. PubMed ID: 7509095
[No Abstract] [Full Text] [Related]
6. Applications of topical immunomodulators enhance clinical signs of vernal keratoconjunctivitis (VKC) and atopic keratoconjunctivitis (AKC): a meta-analysis.
Erdinest N; Noyman DBE; London N; Lavy I; Levinger N; Landau D; Solomon A; Morad Y; Naroo SA
Int Ophthalmol; 2024 Mar; 44(1):157. PubMed ID: 38522059
[TBL] [Abstract][Full Text] [Related]
7. The effectiveness of tacrolimus and minidose methotrexate in the prevention of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in children: a single-center study in Korea.
Park SS; Jun SE; Lim YT
Korean J Hematol; 2012 Jun; 47(2):113-8. PubMed ID: 22783357
[TBL] [Abstract][Full Text] [Related]
8. Increasing incidence of new-onset diabetes after transplant among pediatric renal transplant patients.
Burroughs TE; Swindle JP; Salvalaggio PR; Lentine KL; Takemoto SK; Bunnapradist S; Brennan DC; Schnitzler MA
Transplantation; 2009 Aug; 88(3):367-73. PubMed ID: 19667939
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.
Staatz CE; Tett SE
Clin Pharmacokinet; 2004; 43(10):623-53. PubMed ID: 15244495
[TBL] [Abstract][Full Text] [Related]
10. Therapy for acute rejection in pediatric organ transplant recipients.
Debray D; Furlan V; Baudouin V; Houyel L; Lacaille F; Chardot C
Paediatr Drugs; 2003; 5(2):81-93. PubMed ID: 12529161
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of clinically relevant drug interactions associated with tacrolimus.
Christians U; Jacobsen W; Benet LZ; Lampen A
Clin Pharmacokinet; 2002; 41(11):813-51. PubMed ID: 12190331
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive therapy for paediatric transplant patients: pharmacokinetic considerations.
del Mar Fernández De Gatta M; Santos-Buelga D; Domínguez-Gil A; García MJ
Clin Pharmacokinet; 2002; 41(2):115-35. PubMed ID: 11888332
[TBL] [Abstract][Full Text] [Related]
13. Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression.
Shapiro R; Nalesnik M; McCauley J; Fedorek S; Jordan ML; Scantlebury VP; Jain A; Vivas C; Ellis D; Lombardozzi-Lane S; Randhawa P; Johnston J; Hakala TR; Simmons RL; Fung JJ; Starzl TE
Transplantation; 1999 Dec; 68(12):1851-4. PubMed ID: 10628763
[TBL] [Abstract][Full Text] [Related]
14. Tacrolimus in pediatric renal transplantation: a review.
Shapiro R
Pediatr Transplant; 1998 Nov; 2(4):270-6. PubMed ID: 10084728
[TBL] [Abstract][Full Text] [Related]
15. Conversion from cyclosporine to tacrolimus in pediatric kidney transplant recipients.
Ferraresso M; Ghio L; Edefonti A; Garavaglia R; Berardinelli L
Pediatr Nephrol; 2002 Aug; 17(8):664-7. PubMed ID: 12185478
[TBL] [Abstract][Full Text] [Related]
16. Four-year data after pediatric renal transplantation: a randomized trial of tacrolimus vs. cyclosporin microemulsion.
Filler G; Webb NJ; Milford DV; Watson AR; Gellermann J; Tyden G; Grenda R; Vondrak K; Hughes D; Offner G; Griebel M; Brekke IB; McGraw M; Balzar E; Friman S; Trompeter R
Pediatr Transplant; 2005 Aug; 9(4):498-503. PubMed ID: 16048603
[TBL] [Abstract][Full Text] [Related]
17. Single-center experience with tacrolimus versus cyclosporine-Neoral in renal transplant recipients.
Boots JM; van Duijnhoven EM; Christiaans MH; Nieman FH; van Suylen RJ; van Hooff JP
Transpl Int; 2001 Dec; 14(6):370-83. PubMed ID: 11793034
[TBL] [Abstract][Full Text] [Related]
18. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
Nashan B
Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
[TBL] [Abstract][Full Text] [Related]
19. Progress in pediatric kidney transplantation.
Filler G; Huang SH
Ther Drug Monit; 2010 Jun; 32(3):250-2. PubMed ID: 20431507
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
